Cubist Pharmaceuticals, Inc

Published Date: 14/06/2011
Category: Therapies & Markets

Research Report Decription

Cubist Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

• Detailed information on Cubist Pharmaceuticals, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Cubist Pharmaceuticals, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Cubist Pharmaceuticals, Inc. including a breakdown and examination of key business segments
• Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Cubist Pharmaceuticals, Inc.
• Intelligence on Cubist Pharmaceuticals, Inc.nv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Cubist Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Key Questions Answered:

• Gain understanding of the Cubist Pharmaceuticals, Inc. and the factors that influence its strategies 
• Track strategic initiatives of the company and latest corporate news and actions 
• Assess Cubist Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
• Support sales activities by understanding your customers' businesses better
• Stay up to date on Cubist Pharmaceuticals, Inc.’s business structure, strategy and prospects

Companies Mentioned:

Cubist Pharmaceuticals, Inc.

Paper Highlights:

Cubist Pharmaceuticals (Cubist), is a biopharmaceutical company focusing on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The company operates primarily in the US. Cubist is headquartered in Lexington, Massachusetts and employed about 600 people as of February 01, 2010. The company recorded revenues of $562.1 million during the financial year (FY) ended December 2009, an increase of 29.6% over FY2008. The operating profit of the company was $137.8 million during FY2009, an increase of 51.6% over FY2008. The net profit was $79.6 million in FY2009, a decrease of 37.8% over FY2008.